Thank you to the people and institutions whose generosity has helped to make the HEALEY ALS Platform Trial possible, starting with Sean M. Healey, AMG and their friends. We are very thankful for our longstanding partnership with The ALS Association, who in addition to committing significant grant support to the HEALEY ALS Platform Trial, has funded ALS researchers at Mass General for more than a decade. Because of the support of The ALS Association for the Northeast ALS Consortium through their TREAT ALS program, we established the first central IRB for ALS trials and trained over 100 clinical trial sites throughout the United States. This allows us to move much faster to launch the HEALEY ALS Platform Trial.
We are grateful for the support of countless donors and the many individuals with ALS and their family members who have motivated their communities to make an impact. These partners include Tackle ALS, ALS ONE, sALSa For a Cure, participants of the Ice Bucket Challenge 2 launched by IAMALS, and Run2Revive.
Our commitment to advancing treatment and therapies for individuals with ALS encourages us to pursue new funding opportunities and collaborate with our corporate and foundation partners and individual donors in new ways. We look forward to sharing our progress as we work towards our goal: to find a cure for ALS. We can do this together!